Definition

Noun: * An enzyme (a type of protease) that catalyzes the conversion of the inactive proenzyme plasminogen into the active enzyme plasmin. This process initiates fibrinolysis, the breakdown of blood clots.

Usage

• Medical Context: The term is used almost exclusively in medical, biochemical, and pharmacological contexts to describe substances that trigger the body's natural clot-dissolving system.
  • Tissue-type plasminogen activator (tPA) is a critical protein in the breakdown of blood clots.
  • The drug acts as a plasminogen activator to treat acute ischemic stroke.

Advanced Usage

• Therapeutic Agent: Refers specifically to pharmaceutical drugs (e.g., alteplase, reteplase) that are recombinant forms of human tissue plasminogen activator, used as thrombolytic ("clot-busting") therapy.
  • The timely administration of a plasminogen activator can significantly improve outcomes for heart attack patients.

Variants and Related Words

• tPA / t-PA: Abbreviation for "tissue-type plasminogen activator," the primary physiological form of the enzyme.
• Urokinase (uPA): Another type of plasminogen activator, originally isolated from urine.
• Thrombolytic: An adjective or noun describing an agent (like a plasminogen activator drug) that breaks down blood clots.
• Fibrinolytic: An adjective describing the process (fibrinolysis) or agents that dissolve fibrin, the main protein component of blood clots.

Synonyms

• Fibrinolytic agent (in a therapeutic context)
• Thrombolytic agent (in a therapeutic context)

Related Phrases

• Plasminogen activator inhibitor (PAI): A substance that inhibits the function of plasminogen activators, regulating the fibrinolysis process.
  • Elevated levels of plasminogen activator inhibitor-1 are associated with an increased risk of thrombosis.

Noun

1. protease produced in the kidney that converts plasminogen to plasmin and so initiates fibrinolysis